Section Arrow
Quote
GLMD.NASDAQ
- Galmed Pharmaceuticals Ltd
(Financial Status)
Quotes are at least 15-min delayed:2026/04/23 04:34 EDT
Pre Market
Last
 0.6522
-0.0203 (-3.02%)
Bid
0.6522
Ask
0.681
High 0.6939 
Low 0.6503 
Volume 421 
Regular Hours (Closed)
Last
 0.6725
-0.0555 (-7.62%)
Day High 
0.7175 
Prev. Close
0.728 
1-M High
1.26 
Volume 
243.89K 
Bid
0.6522
Ask
0.681
Day Low
0.6501 
Open
0.6991 
1-M Low
0.4111 
Market Cap 
4.80M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.73 
20-SMA 0.64 
50-SMA 0.62 
52-W High 2.68 
52-W Low 0.4111 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.39/-0.76
Enterprise Value
4.80M
Balance Sheet
Book Value Per Share
2.39
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.2224+0.0256+13.01%-- 
Pre Market 0.207 -0.0154 -6.92%
TOVXTheriva Biologics Inc0.3731+0.0344+10.16%0.09PE
Pre Market 0.3447 -0.0284 -7.61%
IOVAIovance Biotherapeutics3.53-0.17-4.59%-- 
Pre Market 3.5244 -0.0056 -0.16%
REPLReplimune Group2.27+0.41+22.04%-- 
Pre Market 2.28 +0.01 +0.44%
GERNGeron Corp1.55+0.05+3.33%-- 
Pre Market 1.56 +0.01 +0.65%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtechspaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.